Investors Chronicle ... (OXB) were down by nearly 10 per cent this morning after the bio- pharma specialist put some of its trials on hold, after the company detected low concentrations of potential impurities in a raw material ...
Moneycontrol.com They import a major chunk of their raw material or maybe the component. The May numbers have been really bad.” ”The surprising part is that their three hot cake models have shown a degrowth and ... 更多 »
